PGEN short interest
Precigen Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 47,547,517 |
|---|---|
| Change vs prior report | 5,269,280 (+12.5%) |
| Change over six months | +19.9% |
| Days to cover | 7.38 (sector: 3.78) |
| Average daily volume | 6,444,570 |
| Rank in Healthcare | #220 of 922 by days to cover |
PGEN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 47,547,517 | +12.5% | 7.38 | 6,444,570 |
| 2026-09-15 | 42,278,237 | +0.2% | 16.27 | 2,598,893 |
| 2026-08-31 | 42,180,337 | -0.1% | 7.91 | 5,332,363 |
| 2026-08-14 | 42,240,157 | +0.5% | 5.85 | 7,214,381 |
| 2026-07-31 | 42,044,362 | +2.5% | 11.12 | 3,779,683 |
| 2026-07-15 | 41,025,860 | -7.2% | 9.62 | 4,263,642 |
| 2026-06-30 | 44,222,506 | +2.0% | 7.61 | 5,810,243 |
| 2026-06-15 | 43,338,122 | +7.7% | 7.39 | 5,866,310 |
| 2026-05-29 | 40,254,841 | +1.0% | 9.56 | 4,211,529 |
| 2026-05-15 | 39,871,277 | +0.2% | 11.05 | 3,607,150 |
| 2026-04-30 | 39,770,522 | -0.1% | 14.51 | 2,741,211 |
| 2026-04-15 | 39,794,906 | +0.3% | 10.77 | 3,696,445 |
| 2026-03-31 | 39,661,787 | -0.3% | 5.62 | 7,056,277 |
| 2026-03-13 | 39,788,994 | -5.0% | 10.61 | 3,750,344 |
| 2026-02-27 | 41,882,137 | +1.9% | 7.54 | 5,551,482 |
| 2026-02-13 | 41,094,402 | -2.1% | 12.86 | 3,195,930 |
| 2026-01-30 | 41,975,778 | +6.5% | 11.67 | 3,597,567 |
| 2026-01-15 | 39,413,898 | +10.8% | 10.06 | 3,919,262 |
| 2025-12-31 | 35,580,646 | +28.2% | 5.15 | 6,911,562 |
| 2025-12-15 | 27,758,985 | -5.7% | 9.81 | 2,830,423 |
| 2025-11-28 | 29,435,025 | +1.9% | 6.77 | 4,347,190 |
| 2025-11-14 | 28,884,978 | -15.9% | 5.78 | 4,993,411 |
| 2025-10-31 | 34,330,841 | +7.1% | 7.46 | 4,599,181 |
| 2025-10-15 | 32,041,619 | -15.1% | 6.58 | 4,865,988 |
| 2025-09-30 | 37,754,111 | +6.8% | 5.63 | 6,706,855 |
import finzdata as yf
yf.Ticker("PGEN").short_interest # every report since 2017
yf.Client().short_interest(["PGEN"], start="2018-01-01")Healthcare short interest · PGEN price history · Who owns PGEN · All short interest